3/20
12:31 pm
lumo
Lumos Pharma, Inc. (NASDAQ: LUMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Medium
Report
Lumos Pharma, Inc. (NASDAQ: LUMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
3/20
08:11 am
lumo
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 [Yahoo! Finance]
High
Report
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 [Yahoo! Finance]
3/20
08:00 am
lumo
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
Medium
Report
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
3/10
08:52 am
lumo
Lumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Lumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
3/8
02:45 pm
lumo
Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/7
04:09 pm
lumo
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update [Yahoo! Finance]
Low
Report
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update [Yahoo! Finance]
3/7
04:01 pm
lumo
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
Low
Report
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
2/26
09:00 am
lumo
Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
Low
Report
Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
8/9/2023
04:01 pm
lumo
lumos pharma, inc.
MISS
Report
-5.8%
lumos pharma, inc.
5/3/2023
04:05 pm
lumo
lumos pharma, inc.
BEAT
Report
9.1%
lumos pharma, inc.
3/20
04:27 pm
lumo
Form 8-K LUMOS PHARMA, INC. For: Mar 20
Low
Report
Form 8-K LUMOS PHARMA, INC. For: Mar 20
3/7
04:49 pm
lumo
Form 10-K LUMOS PHARMA, INC. For: Dec 31
Low
Report
Form 10-K LUMOS PHARMA, INC. For: Dec 31
3/7
04:45 pm
lumo
Form 8-K LUMOS PHARMA, INC. For: Mar 07
Low
Report
Form 8-K LUMOS PHARMA, INC. For: Mar 07
2/9
07:14 pm
lumo
Form SC 13G/A LUMOS PHARMA, INC. Filed by: GOLDMAN SACHS GROUP INC
Medium
Report
Form SC 13G/A LUMOS PHARMA, INC. Filed by: GOLDMAN SACHS GROUP INC
2/7
05:22 pm
lumo
Form 4 LUMOS PHARMA, INC. For: Feb 06 Filed by: McKew John C.
Low
Report
Form 4 LUMOS PHARMA, INC. For: Feb 06 Filed by: McKew John C.
2/6
04:02 pm
lumo
Form 144 LUMOS PHARMA, INC. Filed by: McKew John C.
Low
Report
Form 144 LUMOS PHARMA, INC. Filed by: McKew John C.
2/6
09:57 am
lumo
Form SC 13G LUMOS PHARMA, INC. Filed by: WELLS FARGO & COMPANY/MN
Low
Report
Form SC 13G LUMOS PHARMA, INC. Filed by: WELLS FARGO & COMPANY/MN
2/5
05:56 pm
lumo
Form 4 LUMOS PHARMA, INC. For: Feb 01 Filed by: McKew John C.
Low
Report
Form 4 LUMOS PHARMA, INC. For: Feb 01 Filed by: McKew John C.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register